donderdag 28 februari 2019

#EUfunded GAPVAC researchers have conducted a pioneering human trial of personalised cancer vaccines to pave the way for new treatments for illnesses such as the aggressive brain cancer #glioblastoma ➡️https://t.co/eojsAleRbm #RareDiseaseDay #EUHealth… https://t.co/aw6uBdoIEg


from Twitter https://twitter.com/praatnederlands #euiapress #euinternationalacademy more #EUIAOJ at https://ift.tt/2GeCjyM

Geen opmerkingen:

Een reactie posten